Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
Reza Rastmanesh 1, 2 1The Nutrition Society, London, UK; 2The American Physical Society, College Park, MD, USACorrespondence: Reza RastmaneshPrivate Clinic, #6, Physicians Building, Sarshar Alley, Vali Asr Street, Tajrish, Tehran, 1961835555, IranEmail r.rastmanesh@gmail.comView the original paper...
Main Author: | Rastmanesh R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/metformin-and-malignant-tumors-not-over-the-hill-a-short-comment-lette-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
by: Leng W, et al.
Published: (2021-09-01) -
Metformin and Malignant Tumors: Not Over the Hill
by: Leng W, et al.
Published: (2021-08-01) -
Oral Processing, Satiation and Obesity: Overview and Hypotheses: A Short Comment [Letter]
by: Rastmanesh R
Published: (2021-09-01) -
Comments on “Reasons Why Patients Do Not Return to Sport Post ACL Reconstruction: A Cross-Sectional Study” [Letter]
by: Kalra R, et al.
Published: (2025-02-01) -
Comment on Chen et al. Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin. <i>Biomolecules</i> 2021, <i>11</i>, 1373
by: Nicolai Stransky, et al.
Published: (2022-04-01)